Alkosign Limited has postponed its Board of Directors meeting originally scheduled for November 13, 2026. The meeting has been rescheduled to November 14, 2026, due to unavoidable circumstances.
The primary agenda of the rescheduled board meeting remains unchanged: to consider and approve both the Standalone and Consolidated Unaudited financial results for the half year ended September 30, 2026, along with the Limited Review Report.
The company has confirmed that the trading window for dealing in the company's securities will continue to remain closed for all designated persons and their immediate relatives. The closure period extends until 48 hours after the declaration of the financial results for the half year ended September 30, 2026, to the Stock Exchange.
The communication was digitally signed by Samir Narendra Shah, Managing Director (DIN: 03572442), on November 12, 2026, at 19:06:42 IST.